Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/11/2010

Market Cap

45,703,182,636

Shares Outstanding

1,582,390,000

Weighted SO

3,137,776,702

Total Employees

N/A

Upcoming Earnings

07/31/2024

Similar Tickers

VTRS --.--%

ELAN --.--%

ZTS --.--%

EBS --.--%

PBH --.--%

AMPH --.--%

DCPH --.--%

PCRX --.--%

COLL --.--%

Beta

0.5010

Last Div

0.5800

Range

12.58-16.39

Chg

0.0450

Avg Vol

2066450

Mkt Cap

45703182636

Exch

NYSE

Country

JP

Phone

81 3 3278 2111

DCF Diff

305.0620

DCF

321.0920

Div Yield

0.0388

P/S

1.5294

EV Multiple

8.8465

P/FV

0.4304

Div Yield %

3.8782

P/E

22.3868

PEG

3.2582

Payout

1.9647

Current Ratio

1.2606

Quick Ratio

0.7427

Cash Ratio

0.3262

DSO

63.8807

DIO

281.5175

Op Cycle

345.3982

DPO

103.3872

CCC

242.0110

Gross Margin

0.6249

Op Margin

0.1048

Pretax Margin

0.0116

Net Margin

0.0340

Eff Tax Rate

-1.8649

ROA

0.0092

ROE

0.0208

ROCE

0.0336

NI/EBT

2.9206

EBT/EBIT

0.1110

EBIT/Rev

0.1048

Debt Ratio

0.3378

D/E

0.7028

LT Debt/Cap

0.3927

Total Debt/Cap

0.4127

Int Coverage

2.1029

CF/Debt

0.1418

Equity Multi

2.0809

Rec Turnover

5.7138

Pay Turnover

3.5304

Inv Turnover

1.2965

FA Turnover

2.1162

Asset Turnover

0.2720

OCF/Share

495.3772

FCF/Share

272.7451

Cash/Share

512.6293

OCF/Sales

0.1761

FCF/OCF

0.5506

CF Coverage

0.1418

ST Coverage

1.7714

CapEx Coverage

2.2251

Div&CapEx Cov

1.2071

P/BV

0.4304

P/B

0.4304

P/S

1.5294

P/E

22.3868

P/FCF

15.7733

P/OCF

4.3183

P/CF

4.3183

PEG

3.2582

P/S

1.5294

EV Multiple

8.8465

P/FV

0.4304

DPS

0.5618

Latest Headlines (EST)

GlobeNewswire Inc. Jun 19, 18:11 Labviva Showcases Advanced AI Procurement Tools at the R&D Procurement and Sourcing in Pharma Summit 2025 GlobeNewswire Inc. May 12, 22:41 Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance GlobeNewswire Inc. Dec 03, 00:30 Activated Carbon Fiber (ACF) Market to Surpass Valuation of USD 762.85 Million by 2031 | SkyQuest Technology GlobeNewswire Inc. Nov 22, 04:30 HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan GlobeNewswire Inc. Sep 22, 04:30 Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight GlobeNewswire Inc. Aug 22, 21:30 Targeted Therapeutics Market is Pioneering Growth Towards a USD 118.6 Billion Milestone by 2031, with a CAGR of 6.4% - Exclusive Report by Transparency Market Research, Inc. The Motley Fool Dec 22, 05:35 One Ultra-Cheap High-Yield Dividend Stock to Buy Benzinga Dec 19, 14:23 Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach Benzinga Dec 15, 12:46 Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session GlobeNewswire Inc. Dec 06, 16:15 Aurora Technology Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Deadline to Consummate Business Combination Benzinga Nov 10, 13:43 Why Is Neurocrine Biosciences Stock Trading Lower Today?

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.30 03/27/2024 11/30/-0001 03/28/2024 11/30/-0001
0.26 09/28/2023 09/13/2023 09/29/2023 12/11/2023
0.27 09/29/2022 09/13/2022 09/30/2022 12/12/2022